untitled

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "untitled"

Transcription

1

2

3 quality of lifeqol research guideline training practice

4 4 QOL QOL

5

6 SIGSpecial Interest Group

7 7

8

9

10

11 WEB NHK

12 No WEB / / 6 P412 7 P426 12

13 p

14 / / No ADL PPT A5 2 SB 7 14

15 Problem OP OP step POD POD 14 1 / 15 /

16 R Cancer Information Japan PDQ R be.org/web No. PDQ

17 /

18

19 /

20 / LCH

21 No. PDQ 1 QOL LCH QOL /

22 3 QOL / / cognitive-reframing QOL 22

23 / QOL QOL / / QOL QOL /

24 12 QOL / QOL / QOL / QOL / QOL / QOL /

25 18 QOL / QOL /

26 WEB No NPO

27 QOL WOC WOCN 27

28 NHK No

29 3 NHK NTT 1 9 VTR

30 E

31 12 E ""

32 No , , LIFE 15 2, , , ,

33 , ,

34 / / No

35 NHK ALLAY

36 NHK PTOT BP

37 BP NHK AERA NHK NHK

38 NHK NHK THEMIS STORY

39 amazon WEB , No Jack E Thomas Robert L Keith

40 11 12 Diana Stumm %

41 e-learning A B C D E A B C D , E , A B C D E

42 A B C D E A B C 39, D E A B C D E A B C D E

43 A B C D E A B C D E A B C D E A B C D E

44 A B C D E

45 MSW

46 % 10% 20% 30% 40% 50% 60% 70% 80% 90% 100 %

47 3 Web WEB NHK5 WEB NHK Q 47

48 e-learning

49 49

50 quality of lifeqol Subspeciality QOL QOL activities of daily living ADL instrumental activities of daily livingiadl QOL QOL 50

51 WEB WEB 51

52

53 11 B b c d 18 B f A b 6 A B C D E 7 A B C D E A E o A E b e 53

54 8 A B C D E 9 A B 10 C D E A B C D E A E c A E a b c d e f g A E i 3 B d 3 B d I e 54

55 A B 6 A O B C D E 55

56 7 A B C D E 8 A B C D E 9 A B C D E 10 A B C D E e c i 3 I e 4 I e ADL

57 B E 1 D c 4 F b 5 A h d B d e C f a c D 6 C a b c d 2 C a b c 57

58 1 B E b 1 a b c 1 2 3TE 4 d 1 2 3TE 2 D c

59

60

61

62

63 p % 9 p %

64 4 2, , % % p p p

65

66 ADL QOL ADLQOL ADLQOL

67 WEB , WEB CN 67

68 ,082 77, %1, % 0.2% %25 0.2% % 18.7% ,196 44, %

69 *

70 *

71 * , , * 71

72

73

74

75 () 2 75

76

77 77

78 78

79 79

80 80

81 81

82 82

83 SIG Special Interest Group 83

84 84

85 1, :., : 2010, : 4 14., : , : : : 2.,

86

87 87

88 quality of lifeqol 1 23 A

89 ,

90 Hamag 2 uchi 1 A 1,693 5 A K K

91 DVT K 91

92 K K

93 A 90 A nt/f417303/p html 93

94 94

95 415 1 A B C D 5024 E F G 1904 H I A 25 B 3 C 95

96

97 TS

98 K / 98

99 activities of daily living ADL / QOL 14 99

100

101 ADL 3 1 Hamaguchi T, Okamura H, Nakaya N, et al: Survey of the current status of cancer rehabilitation in Japan. Disabil Rehabil 30: , ,,, :. 70: , ,,, :. Jpn J Rehabil Med 47: 488, ,,, :. Jpn J Rehabil Med 47: S167, ,,, :. 12: 2-7, ,,, : 1 Jpn J Rehabil Med 47: 486, ,,, : QOL. 36: , ,,, :. 14: 475, :. MED REHABIL 111: 45-50, ,,, :. Jpn J Rehabil Med 47: , ,, :. 47: ,

102

103 103

104 QOL

105

106

107 MEDLINE MEDLINE cancer rehabilitation japan MEDLINE

108 MEDLINE

109 MEDLINE MEDLINE MEDLINE MEDLINE randomized controlled trialrct Ia RCT Ib IIa IIb III IV I 109

110 Ia RCT RCT Ib RCT IIa IIb III IV MEDLINE Ia 18 Ib 215 IIa 19 IIb III IV MEDLINE MEDLINE 2000 I RCT 110

111 QOL

112 CLINICAL REHABILITATION

113 MD Rajesh R. Yadav

114

115 115

116 TEL

342 1 42% 20% 90 2000 10 1 1 1 QOL 1) 4 2063 99 86.9 ADL A1 B2 IIIa M 1 5 QOL 2) QOL 3 QOL 59.4 3 73.1 23.1% QOL 3 QOL QOL 11 5 4 M 1 IV 1 1 IIIb 8 2

342 1 42% 20% 90 2000 10 1 1 1 QOL 1) 4 2063 99 86.9 ADL A1 B2 IIIa M 1 5 QOL 2) QOL 3 QOL 59.4 3 73.1 23.1% QOL 3 QOL QOL 11 5 4 M 1 IV 1 1 IIIb 8 2 2012 341 352 Psychotherapy in Medical Welfare 1 Tomohisa SASANO 2 1 701-0193 288 E-Mail: sasano@mw.kawasaki-m.ac.jp 341 342 1 42% 20% 90 2000 10 1 1 1 QOL 1) 4 2063 99 86.9 ADL A1 B2 IIIa M 1 5 QOL 2)

More information

障害者職域拡大カリキュラム研究会中間報告書構成案

障害者職域拡大カリキュラム研究会中間報告書構成案 3 4 5 5 7 7 9 () 9 ()23 34 1 36 47 49 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ADL QOL 36 37 38 39 40 41 42 43 44 45 46 16 8 () 19 ( ) () 21 () 47 16

More information

エンジョイ北スポーツ

エンジョイ北スポーツ 2772083130 83 1 2 3 4 5 6 7 8 2 2 2 3 3 4 4 6 7 8 1211 53 /15,171 /509 /670 /13,992 2 83130 http://www.kita-city-taikyo.or.jp 83130 http://www.kita-city-taikyo.or.jp 3 68 35 45 4 83130 http://www.kita-city-taikyo.or.jp

More information

表1票4.qx4

表1票4.qx4 iii iv v 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 22 23 10 11 24 25 26 27 10 56 28 11 29 30 12 13 14 15 16 17 18 19 2010 2111 22 23 2412 2513 14 31 17 32 18 33 19 34 20 35 21 36 24 37 25 38 2614

More information

第1節 災害体制の確立

第1節 災害体制の確立 (2) 1 (3) (4) 2 3 4 5 3 6 7 8 9 10 NHK 11 12 13 14 15 16 17 18 19 20 21 22 23 391 391 24 68 25 26 FAX 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

More information

久留米市地域防災計画

久留米市地域防災計画 (2) 1 (3) (4) 2 3 4 3 5 6 7 NHK 8 9 10 11 12 13 14 15 16 17 18 19 20 391 391 68 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61

More information

r e -

r e - A A e r t y u i o!0 r e - i i i i i i i yi i y y i r e r e euo!0 u eo!0 e e o u!0 o t r e e e er e r e r C D A B C A i A ii A iii A B D A iv - e r r e AA ia iia iii A iva - SPECIAL GEAR & ACCESSORIES

More information

ito.dvi

ito.dvi 1 2 1006 214 542 160 120 160 1 1916 49 1710 55 1716 1 2 1995 1 2 3 4 2 3 1950 1973 1969 1989 1 4 3 3.1 3.1.1 1989 2 3.1.2 214 542 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

More information

i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii

More information

437“ƒ

437“ƒ et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

More information

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2) (1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46

More information

1 2 3 4 1 3 4 2 5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 21 24 25 26 27 28 29 30 31 32 33 34 9 35 36 14 9 14 15 37 38 39 35 1 519 4 NPO 40 41 9 10 4 (9 Or10 ) PR 3 21 21 42 2 10 43 44 15

More information

10 12 13 16 17 26 26 31 32 33 33 35 37 38 39 42 43 44 2 15 5 15 57 17 16 4 16 4 2 JA 16 7 1 10 22 11 9 12 6 12 2 12 24 17 1 6 JA 3 4 5 16 7 1 6 ( ) ( ) 15 ( ) ( ) ( ) ( ) ( ) 16 3 35 37 1 93 223 ( ) 218

More information

がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性

がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性 2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4

More information

2

2 1 2 17 1884 2 131 1 1..He lived to serve 2 2 2 2 14,416 104,000 1 QOL Quality of Life 2 21 2013 25 21 3 4 5 QOL 6 QOL QOL 59 1 60 7 QOL QOL 8 2,774 2015 27 5 7 241 2015 27 5 8 12 2015 3 7 58 1,030 113

More information

CRPNo30表紙.ai

CRPNo30表紙.ai No.30 2012/6 20126 Clinical Research Professionals No.30 17 18 Clinical Research Professionals No.30 2012 6 20126 Clinical Research Professionals No.30 19 20 Clinical Research Professionals No.30 2012

More information

06佐々木雅哉_4C.indd

06佐々木雅哉_4C.indd 3 2 3 2 4 5 56 57 3 2013 9 2012 16 19 62.2 17 2013 7 170 77 170 131 58 9 10 59 3 2 10 15 F 12 12 48 60 1 3 1 4 7 61 3 7 1 62 T C C T C C1 2 3 T C 1 C 1 T C C C T T C T C C 63 3 T 4 T C C T C C CN T C C

More information

NEXT STEP

NEXT STEP NEXT STEP NEXT STEP 1 2 6 1 12 19 21 22 24 25 25 24 23 22 21 25 55,171 49,46 45,426 42,666 43,174 $ 514,79 39,719 35,943 32,727 32,726 32,769 37,99 5,41 6,44 6,775 5,313 4,664 5,326 2,256 2,45 2,77 2,792

More information

iii iv v vi 21 A B A B C C 1 1 2 3 4 5 6 1 2 3 4 5 6 7 8 9 10 11 19 22 30 39 43 48 54 60 65 74 77 84 87 89 95 101 12 20 23 31 40 44 49 55 61 66 75 78 85 88 90 96 102 13 21 24 32 41 45 50 56 62 67 76 79

More information

中京女子NO23_M+K

中京女子NO23_M+K 2008.Sep 23 1 30 1819 1 2 1819 1710119930 2 REPORT 2021 1 2 2021 S40 S45 S52 S52 S52 S43 H15 S45 H2 S34 S40 2021 1910121930 3 4 5 SPECIAL 45 52 5 40 TOPICS 20723 17,43112,625 1. 8 2. 21 1016 3. * * 793

More information

untitled

untitled -1- 12 3 7 8 3.5 ( ) 7 8 3 1 2 3 ( ) ( -2- 3 7 5 21 2 2-3- 2 2 18 ( 1) ( 1) ( ) 6. 9 ( 9 15 ) 7. 2 ( 9 ) ( 11 32 11 ) 11. 4 20. 10 ( 26 15 21 ) 23. 9 28. 4 ( 8 ) ( 34 ) 32. 9 ( 45 ) 32. 12 ( 10 13 ) 33.

More information

1926

1926 2010 10 2011 2 3 3 19 2010:369 1970 4 1 2 3 4 1 2 4 3 2010 11 1926 2011a:80 2011a:81 2008:27 2001a:82 2001a:85 2001a:82-3 2001a:95 2001b:32-3 2001b:32 2001b:33 2009:65 2005 2005:3 2005:4 2005:8 2005:8

More information

1 発病のとき

1 発病のとき A A 1944 19 60 A 1 A 20 40 2 A 4 A A 23 6 A A 13 10 100 2 2 360 A 19 2 5 A A A A A TS TS A A A 194823 6 A A 23 A 361 A 3 2 4 2 16 9 A 7 18 A A 16 4 16 3 362 A A 6 A 6 4 A A 363 A 1 A A 1 A A 364 A 1 A

More information

21 22 4 5 23 3 11 24 4 23 FAQ 2

21 22 4 5 23 3 11 24 4 23 FAQ 2 21 22 4 5 23 3 11 24 4 23 FAQ 2 3 4 A 15 5 8 19 13 19 5 6 14 5 16 5 9 20 22 18 B 29 30 5 17 47 51 26 18 21 22 27 5 3 48 103 11 3 10 C 7 22 44 103 107 117 127 7 18 5 7 8 5 1 2011 5 24 2 6 22 3 7 27 4 9

More information

橡Taro11-報告書0.PDF

橡Taro11-報告書0.PDF Research Center RC 2001 5-1- RC RC NHK -2- -3- 00/12/16 RC 01/01/07 RC 01/01/21 1 13 01/02/11 2 9 01/02/10 01/02/14 01/02/19 01/02/25 3 7 01/03/10 4 8 01/03/23 5 8 01/04/29 2001/01/07-4- -5- RC 1990 RC

More information

i

i 14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7

More information

- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...

- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8... 取 扱 説 明 書 - - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...9...11 - - - - - - - - - - - - - - - - -

More information

(個別のテーマ) 薬剤に関連した医療事故

(個別のテーマ) 薬剤に関連した医療事故 - 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89

More information

(個別のテーマ) 放射線検査に関連した医療事故

(個別のテーマ) 放射線検査に関連した医療事故 - 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -

More information

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - 6 Qol Quality of Life - 22 - - 23 - - 24 - 7 8 9-25 - 10 Forest

More information

2014 12 13 1 2 1 2 50 15 6 3 2 5 3 14 14 1980 1997 1991 1996 97 2000 2003 2005 97 2000 3 PTA Bar Mitzvah 13 3 2008 PTA 1997 2010 2 40 50 2 2 A B 2 A B 2 1 50 C C 1 2 A A PTA LINE LINE A A A B B B 2008

More information

PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article 1 1. 2. MeSH Browser MeSH PreMEDLINE MeSH -2-

PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article 1 1. 2. MeSH Browser MeSH PreMEDLINE MeSH -2- PubMed MEDLINE NLM 1879 Index Medicus 1960 MEDLARS Medical Literature Analysis and Retrieval System 1970 MEDLINE MEDlars online 1966 70 4,000 170 PubMed MEDLINE NLM National Center for Biotechnology Information

More information

P072-076.indd

P072-076.indd 3 STEP0 STEP1 STEP2 STEP3 STEP4 072 3STEP4 STEP3 STEP2 STEP1 STEP0 073 3 STEP0 STEP1 STEP2 STEP3 STEP4 074 3STEP4 STEP3 STEP2 STEP1 STEP0 075 3 STEP0 STEP1 STEP2 STEP3 STEP4 076 3STEP4 STEP3 STEP2 STEP1

More information

STEP1 STEP3 STEP2 STEP4 STEP6 STEP5 STEP7 10,000,000 2,060 38 0 0 0 1978 4 1 2015 9 30 15,000,000 2,060 38 0 0 0 197941 2016930 10,000,000 2,060 38 0 0 0 197941 2016930 3 000 000 0 0 0 600 15

More information

1

1 1 2 3 4 5 6 7 8 9 0 1 2 6 3 1 2 3 4 5 6 7 8 9 0 5 4 STEP 02 STEP 01 STEP 03 STEP 04 1F 1F 2F 2F 2F 1F 1 2 3 4 5 http://smarthouse-center.org/sdk/ http://smarthouse-center.org/inquiries/ http://sh-center.org/

More information

第1部 一般的コメント

第1部 一般的コメント (( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12

More information

第1章 国民年金における無年金

第1章 国民年金における無年金 1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20

More information

安全・安心な社会を目指して―現代社会病理の背景に関する有識者ヒアリングとりまとめ-

安全・安心な社会を目指して―現代社会病理の背景に関する有識者ヒアリングとりまとめ- 1 http://www.esri.go.jp/jp/prj/social/social_main.html 2 3 4 5 I 1990 2 II 16 6 20 3,000 2,136 71.2 16 15 16 20 50 3001 55.9 65.8 64.0 55.6 51.4 50 60 3 4 30 50 40 40 30 30 5 79.4 86.1 67.8 44.6 48.8 41.1

More information

平成21年度

平成21年度 ..................... 1 1 2 2 3 4 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1 1 1 2 2 3 4 5 6 7 8 9 10 11 1 1 12 13 2 14 3 4 15 16 17 18 19 6 20 21 22 23 24 9 10 25 26 27 28 29 30 31 32 33 34 35 36

More information

ÿþ

ÿþ I O 01 II O III IV 02 II O 03 II O III IV III IV 04 II O III IV III IV 05 II O III IV 06 III O 07 III O 08 III 09 O III O 10 IV O 11 IV O 12 V O 13 V O 14 V O 15 O ( - ) ( - ) 16 本 校 志 望 の 理 由 入 学 後 の

More information

( )

( ) Web Web 1 3 1 21 11 22 23 24 3 2 3 4 5 1 1 11 22 9 2 3 15 11 22 2 11 21 4 5 ( ) 102 ( ) 1 ( 1 2001 Web 1 5 4 1 1 - 7 - [] - 7 10 11 12 12 1 10 1 12 - [] 1 1 2 Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 3 1 47

More information

夏目小兵衛直克

夏目小兵衛直克 39(1906)1222 14(1817) 3(1832)1514(1843) 2628 6 (1853) (1854)3727 3(1856) 1 / 13 5(1858)6(1859) 5(1853) () () () () () () 3(1867)29 504111( 2 / 13 )98 23 18 2(1869)310283 100 50() 58 226 3313200982 5033

More information

nenkin.PDF

nenkin.PDF 1 31 1 WEB 10 3,544 429 13 10 22 11 7 WEB 1 2 41.0 15 80.0 20 46.7% 1000 55.8 1000 34.4 21 18.2 1000 23 25 41.0 49.2 29 90.6 42.7 33 56.4% 79.2% 67.4 51.7 37 39 83.7 1 91.0 93.6 9 2 3 1000 96.3 300 1000

More information

untitled

untitled 2010 Winter 2 No. PRACTICE 2010 Winter No. 2 PRACTICE 4 8 14 10 16 12 18 26 30 34 38 39 40 42 44 46 49 51 56 54 60 64 66 67 68 4 PRACTICE 5 PRACTICE 6 7 PRACTICE 8 PRACTICE 9 PRACTICE 10 PRACTICE 11 PRACTICE

More information

A A OT 2 A OT A OT A A OT 4 OT A A OT A OT A OT A 3 OT 1 2 OT 2 2 1 2014105 26.5.12 26.5.27 26.6.4 26.9/116 OTPT 10/101 26.9.292 26.6/26 26.5/2727.5/31 2/ 2/ H26.10.177 26.10.21 22 27.2 27.3 27.4.1 27.4.21

More information

- 2 -

- 2 - - 1 - - 2 - - 3 - - 4 - 1 1 1 2 2 2 3 3 4 4 4 5 5 6 6 7 7 7 23 9 13 13 13 15 16 16 17 17 17 19 21 22 23 25 25 26 26 26 28-1 - 30 31 32 32 33 43 51 51 52 52 52 54 56 57 58 58 59 72 74 75 76 76 77 81 82

More information

奄美地域の自然資源の保全・活用に関する基本的な考え方(案)

奄美地域の自然資源の保全・活用に関する基本的な考え方(案) 1 15 5 15 16 19 20 2 3 10 25,000 30,000 6 8 710 11 16 4 1213 1415 17 17 28 17 126,483 30 5 70,462 8,572 27,167 14,551 5,731 29 18 560 10 1,032 1 6 1,300 47 28 4 19 1 8 23 17 100 7 15 8 NPO IT 1979 9 NPO

More information

20110124-02-01

20110124-02-01 100 13 13 148 4 60 8 21 18 3 2 19 2 23 3 22 22 9 23 10 1 2 18 3 3 60.0 31.12 33.3 24.5 23.1 22.7 29 201714 22 13.310 32 12.137 11.2 65 22 20.532 27.437 28.7 18 1 46.31 81.6 20.9 23.821.4 19.0 34.9 28.9

More information

- 82 -

- 82 - - 82 - 1 2 3 4 5 6-83 - 7 3,000 100 8 9 10 11 4559 59 24 51 61 51-84 - 5373-85 - 3,000 100 3,000 12 100-86 - 1,000 44 5462-87 - 3,000 23 24 10,000 23 8,000 24 2,000 22 2,000 23 22 2,000 8,000 3,000 22

More information

- -

- - - - NPO A B C D A D - - - - - 63 - NPO 法 人 の 申 告 手 続 きについて NPO () 収 益 事 業 を 行 っている 場 合 収 益 事 業 を 行 っていない 場 合 (086)233-9816 (086)233-9820 700-8604 6-1 (086)434-7016 710-8530 1083 (0868)23-1272 708-8506

More information

5 10 10-1 - 5 20-2 - - 3 - - 4 - 22 6 30 10 12 22 7 8 1 30 4 30 1 22 7 14 10 12 20 22 7 21 1 30 3 30-5 - - 6 - - 7 - 11 9 9 14 10 9 15 7 9 10 NPO - 8 - - 15 - - 16 - - 17 - - 19 - - 20 - - 21 - - 22

More information